{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["cancer", "cellular signaling pathways", "natural extract", "target identification"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35682652", "DateCompleted": {"Year": "2022", "Month": "06", "Day": "13"}, "DateRevised": {"Year": "2022", "Month": "07", "Day": "16"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "05", "Day": "26"}], "Language": ["eng"], "ELocationID": ["5972", "10.3390/ijms23115972"], "Journal": {"ISSN": "1422-0067", "JournalIssue": {"Volume": "23", "Issue": "11", "PubDate": {"Year": "2022", "Month": "May", "Day": "26"}}, "Title": "International journal of molecular sciences", "ISOAbbreviation": "Int J Mol Sci"}, "ArticleTitle": "Mechanisms of Natural Extracts of <i>Andrographis paniculata</i> That Target Lipid-Dependent Cancer Pathways: A View from the Signaling Pathway.", "Abstract": {"AbstractText": ["<i>Andrographis paniculata</i> is a local medicinal plant that is widely cultivated in Malaysia. It is comprised of numerous bioactive compounds that can be isolated using water, ethanol or methanol. Among these compounds, andrographolide has been found to be the major compound and it exhibits varieties of pharmacological activities, including anti-cancer properties, particularly in the lipid-dependent cancer pathway. Lipids act as crucial membrane-building elements, fuel for energy-demanding activities, signaling molecules, and regulators of several cellular functions. Studies have shown that alterations in lipid composition assist cancer cells in changing microenvironments. Thus, compounds that target the lipid pathway might serve as potential anti-cancer therapeutic agents. The purpose of this review is to provide an overview of the medicinal chemistry and pharmacology of <i>A. paniculata</i> and its active compounds in terms of anti-cancer activity, primary mechanism of action, and cellular targets, particularly in the lipid-dependent cancer pathway."]}, "AuthorList": [{"Identifier": ["0000-0002-7937-1255"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Human Anatomy, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang 43400, Malaysia."}], "LastName": "Naomi", "ForeName": "Ruth", "Initials": "R"}, {"Identifier": ["0000-0001-8302-4136"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Human Anatomy, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang 43400, Malaysia."}], "LastName": "Bahari", "ForeName": "Hasnah", "Initials": "H"}, {"Identifier": ["0000-0002-8300-6955"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Psychology, University of New South Wales, Sydney 2052, Australia."}], "LastName": "Ong", "ForeName": "Zhi Yi", "Initials": "ZY"}, {"Identifier": ["0000-0002-9442-7456"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Human Anatomy, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang 43400, Malaysia."}], "LastName": "Keong", "ForeName": "Yong Yoke", "Initials": "YY"}, {"Identifier": ["0000-0002-0536-2145"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Emergency Medicine, Faculty of Medicine, Universiti Kebangsaan Malaysia, Kuala Lumpur 56000, Malaysia."}], "LastName": "Embong", "ForeName": "Hashim", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Surgery, Faculty of Medicine, Universiti Malaya, Kuala Lumpur 50603, Malaysia."}], "LastName": "Rajandram", "ForeName": "Retnagowri", "Initials": "R"}, {"Identifier": ["0000-0002-5735-6441"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Advanced Medical and Dental Institute, Universiti Sains Malaysia, Penang 13200, Malaysia."}], "LastName": "Teoh", "ForeName": "Soo Huat", "Initials": "SH"}, {"Identifier": ["0000-0002-0924-6264"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang 43400, Malaysia."}], "LastName": "Othman", "ForeName": "Fezah", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Bioprocess and Polymer Engineering, School of Chemical and Energy Engineering, Faculty of Engineering, Universiti Teknologi Malaysia, Johor Bahru 81310, Malaysia."}], "LastName": "Hasham", "ForeName": "Rosnani", "Initials": "R"}, {"Identifier": ["0000-0003-1915-6606"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute for Research in Molecular Medicine (INFORMM), Universiti Sains Malaysia, Penang 11800, Malaysia."}], "LastName": "Yin", "ForeName": "Khoo Boon", "Initials": "KB"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Microbiology & Parasitology, Faculty of Medicine & Health Science, Universiti Putra Malaysia, Serdang 43400, Malaysia."}], "LastName": "Kaniappan", "ForeName": "Priyatharisni", "Initials": "P"}, {"Identifier": ["0000-0001-6162-4405"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Centre for Tissue Engineering and Regenerative Medicine, Faculty of Medicine, Universiti Kebangsaan Malaysia, Cheras, Kuala Lumpur 56000, Malaysia."}], "LastName": "Yazid", "ForeName": "Muhammad Dain", "Initials": "MD"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Universiti Malaysia Sabah, Kota Kinabalu 88400, Malaysia."}], "LastName": "Zakaria", "ForeName": "Zainul Amiruddin", "Initials": "ZA"}], "GrantList": [{"GrantID": "Long Term Research Grant Scheme - Malaysia Research University Network (Grant No. 6300262-14001)", "Agency": "Ministry of Higher Education", "Country": ""}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Int J Mol Sci", "NlmUniqueID": "101092791", "ISSNLinking": "1422-0067"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Diterpenes"}, {"RegistryNumber": "0", "NameOfSubstance": "Lipids"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}], "MeshHeadingList": [{"QualifierName": ["chemistry"], "DescriptorName": "Andrographis"}, {"QualifierName": [], "DescriptorName": "Andrographis paniculata"}, {"QualifierName": ["chemistry"], "DescriptorName": "Diterpenes"}, {"QualifierName": [], "DescriptorName": "Lipids"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Neoplasms"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Plant Extracts"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Signal Transduction"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Koparde A.A., Doijad R.C., Magdum C.S. Natural Products in Drug Discovery. In: Perveen S., Al-Taweel A., editors. Pharmacognosy\u2014Medicinal Plants. IntechOpen; Malkapur, India: 2019."}, {"Citation": "Bakar F.I.A., Bakar M.F.A., Abdullah N., Endrini S., Rahmat A. A Review of Malaysian Medicinal Plants with Potential Anti-Inflammatory Activity. Adv. Pharmacol. Sci. 2018;2018:8603602. doi: 10.1155/2018/8603602.", "ArticleIdList": ["10.1155/2018/8603602", "PMC6079619", "30123256"]}, {"Citation": "Tan T.Y.C., Lee J.C., Mohd Yusof N.A., Teh B.P., Mohamed A.F.S. Malaysian herbal monograph development and challenges. J. Herb. Med. 2020;23:100380. doi: 10.1016/j.hermed.2020.100380.", "ArticleIdList": ["10.1016/j.hermed.2020.100380"]}, {"Citation": "Girish C., Pradhan S.C. Herbal Drugs on the Liver. In: Muriel P., editor. Liver Pathophysiology: Therapies and Antioxidants. Elsevier; Mexico City, Mexico: 2017. pp. 605\u2013620."}, {"Citation": "Akbar S. Handbook of 200 Medicinal Plants: A Comprehensive Review of Their Traditional Medical Uses and Scientific Justifications. Springer International Publishing; Stockton, CA, USA: 2020."}, {"Citation": "Okhuarobo A., Ehizogie Falodun J., Erharuyi O., Imieje V., Falodun A., Langer P. Harnessing the medicinal properties of Andrographis paniculata for diseases and beyond: A review of its phytochemistry and pharmacology. Asian Pac. J. Trop. Dis. 2014;4:213\u2013222. doi: 10.1016/S2222-1808(14)60509-0.", "ArticleIdList": ["10.1016/S2222-1808(14)60509-0"]}, {"Citation": "Hossain S., Urbi Z., Karuniawati H., Mohiuddin R.B., Qrimida A.M., Allzrag A.M.M., Ming L.C., Pagano E., Capasso R. Andrographis paniculata (Burm. f.) Wall. ex Nees: An Updated Review of Phytochemistry, Antimicrobial Pharmacology, and Clinical Safety and Efficacy. Life. 2021;11:348. doi: 10.3390/life11040348.", "ArticleIdList": ["10.3390/life11040348", "PMC8072717", "33923529"]}, {"Citation": "Hossain M.S., Urbi Z., Sule A., Rahman K.M.H. Andrographis paniculata (Burm. f.) Wall. ex Nees: A review of ethnobotany, phytochemistry, and pharmacology. Sci. World J. 2014;2014:274905. doi: 10.1155/2014/274905.", "ArticleIdList": ["10.1155/2014/274905", "PMC4408759", "25950015"]}, {"Citation": "Chao W.W., Lin B.F. Isolation and identification of bioactive compounds in Andrographis paniculata (Chuanxinlian) Chin. Med. 2010;5:17. doi: 10.1186/1749-8546-5-17.", "ArticleIdList": ["10.1186/1749-8546-5-17", "PMC2881933", "20465823"]}, {"Citation": "Rafi M., Devi A.F., Syafitri U.D., Heryanto R., Suparto I.H., Amran M.B., Rohman A., Prajogo B., Lim L.W. Classification of Andrographis paniculata extracts by solvent extraction using HPLC fingerprint and chemometric analysis. BMC Res. Notes. 2020;13:56. doi: 10.1186/s13104-020-4920-x.", "ArticleIdList": ["10.1186/s13104-020-4920-x", "PMC7001318", "32019574"]}, {"Citation": "Chauhan E.S., Sharma K., Bist R. Andrographis paniculata: A review of its phytochemistry and pharmacological activities. Res. J. Pharm. Technol. 2019;12:891\u2013900. doi: 10.5958/0974-360X.2019.00153.7.", "ArticleIdList": ["10.5958/0974-360X.2019.00153.7"]}, {"Citation": "Bhan M., Satija S., Garg C., Dureja H., Garg M. Optimization of ionic liquid-based microwave assisted extraction of a diterpenoid lactone-andrographolide from Andrographis paniculata by response surface methodology. J. Mol. Liq. 2017;229:161\u2013166. doi: 10.1016/j.molliq.2016.12.011.", "ArticleIdList": ["10.1016/j.molliq.2016.12.011"]}, {"Citation": "Samy R.P., Thwin M.M., Gopalakrishnakone P. Phytochemistry, Pharmacology and Clinical Use of Andrographis paniculata. Nat. Prod. Commun. 2007;2:607\u2013618. doi: 10.1177/1934578X0700200519.", "ArticleIdList": ["10.1177/1934578X0700200519"]}, {"Citation": "Sirion U., Kasemsook S., Suksen K., Piyachaturawat P., Suksamrarn A., Saeeng R. New substituted C-19-andrographolide analogues with potent cytotoxic activities. Bioorganic Med. Chem. Lett. 2012;22:49\u201352. doi: 10.1016/j.bmcl.2011.11.085.", "ArticleIdList": ["10.1016/j.bmcl.2011.11.085", "22154665"]}, {"Citation": "Lin F.L., Wu S.J., Lee S.C., Ng L.T. Antioxidant, antioedema and analgesic activities of Andrographis paniculata extracts and their active constituent andrographolide. Phyther. Res. 2009;23:958\u2013964. doi: 10.1002/ptr.2701.", "ArticleIdList": ["10.1002/ptr.2701", "19142986"]}, {"Citation": "R\u00f6hrig F., Schulze A. The multifaceted roles of fatty acid synthesis in cancer. Nat. Rev. Cancer. 2016;16:732\u2013749. doi: 10.1038/nrc.2016.89.", "ArticleIdList": ["10.1038/nrc.2016.89", "27658529"]}, {"Citation": "Butler L.M., Perone Y., Dehairs J., Lupien L.E., de Laat V., Talebi A., Loda M., Kinlaw W.B., Swinnen J.V. Lipids and cancer: Emerging roles in pathogenesis, diagnosis and therapeutic intervention. Adv. Drug Deliv. Rev. 2020;159:245\u2013293. doi: 10.1016/j.addr.2020.07.013.", "ArticleIdList": ["10.1016/j.addr.2020.07.013", "PMC7736102", "32711004"]}, {"Citation": "Kern L., Mittenb\u00fchler M.J., Vesting A.J., Ostermann A.L., Wunderlich C.M., Wunderlich F.T. Obesity-induced TNF\u03b1 and IL-6 signaling: The missing link between obesity and inflammation-driven liver and colorectal cancers. Cancers. 2019;11:24. doi: 10.3390/cancers11010024.", "ArticleIdList": ["10.3390/cancers11010024", "PMC6356226", "30591653"]}, {"Citation": "Hu X., Fatima S., Chen M., Xu K., Huang C., Gong R.H., Su T., Wong H.L.X., Bian Z., Kwan H.Y. Toll-like receptor 4 is a master regulator for colorectal cancer growth under high-fat diet by programming cancer metabolism. Cell Death Dis. 2021;12:1\u201313. doi: 10.1038/s41419-021-04076-x.", "ArticleIdList": ["10.1038/s41419-021-04076-x", "PMC8360949", "34385421"]}, {"Citation": "Wunderlich C.M., Ackermann P.J., Ostermann A.L., Adams-Quack P., Vogt M.C., Tran M.L., Nikolajev A., Waisman A., Garbers C., Theurich S., et al. Obesity exacerbates colitis-associated cancer via IL-6-regulated macrophage polarisation and CCL-20/CCR-6-mediated lymphocyte recruitment. Nat. Commun. 2018;9:1646. doi: 10.1038/s41467-018-03773-0.", "ArticleIdList": ["10.1038/s41467-018-03773-0", "PMC5916940", "29695802"]}, {"Citation": "Divella R., De Luca R., Abbate I., Naglieri E., Daniele A. Obesity and cancer: The role of adipose tissue and adipo-cytokines-induced chronic inflammation. J. Cancer. 2016;7:2359. doi: 10.7150/jca.16884.", "ArticleIdList": ["10.7150/jca.16884", "PMC5166547", "27994674"]}, {"Citation": "Long J., Zhang C.-J., Zhu N., Du K., Yin Y.-F., Tan X., Liao D.-F., Qin L. Lipid metabolism and carcinogenesis, cancer development. Am. J. Cancer Res. 2018;8:791.", "ArticleIdList": ["PMC5992506", "29888102"]}, {"Citation": "Minaya D.M., Turlej A., Joshi A., Nagy T., Weinstein N., DiLorenzo P., Hajnal A., Czaja K. Consumption of a high energy density diet triggers microbiota dysbiosis, hepatic lipidosis, and microglia activation in the nucleus of the solitary tract in rats. Nutr. Diabetes. 2020;10:20. doi: 10.1038/s41387-020-0119-4.", "ArticleIdList": ["10.1038/s41387-020-0119-4", "PMC7283362", "32518225"]}, {"Citation": "Liu T., Guo Z., Song X., Liu L., Dong W., Wang S., Xu M., Yang C., Wang B., Cao H. High-fat diet-induced dysbiosis mediates MCP-1/CCR2 axis-dependent M2 macrophage polarization and promotes intestinal adenoma-adenocarcinoma sequence. J. Cell. Mol. Med. 2020;24:2648\u20132662. doi: 10.1111/jcmm.14984.", "ArticleIdList": ["10.1111/jcmm.14984", "PMC7028862", "31957197"]}, {"Citation": "Venegas D.P., De la Fuente M.K., Landskron G., Gonz\u00e1lez M.J., Quera R., Dijkstra G., Harmsen H.J.M., Faber K.N., Hermoso M.A. Short chain fatty acids (SCFAs)mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases. Front. Immunol. 2019;10:277. doi: 10.3389/fimmu.2019.00277.", "ArticleIdList": ["10.3389/fimmu.2019.00277", "PMC6421268", "30915065"]}, {"Citation": "Iacomino G., Siani A. Role of microRNAs in obesity and obesity-related diseases. Genes Nutr. 2017;12:23. doi: 10.1186/s12263-017-0577-z.", "ArticleIdList": ["10.1186/s12263-017-0577-z", "PMC5613467", "28974990"]}, {"Citation": "Liu L., Nie J., Chen L., Dong G., Du X., Wu X., Tang Y., Han W. The Oncogenic Role of microRNA-130a/301a/454 in Human Colorectal Cancer via Targeting Smad4 Expression. PLoS ONE. 2013;8:e55532. doi: 10.1371/journal.pone.0055532.", "ArticleIdList": ["10.1371/journal.pone.0055532", "PMC3564758", "23393589"]}, {"Citation": "Wang J., Li Y. CD36 tango in cancer: Signaling pathways and functions. Theranostics. 2019;9:4893\u20134908. doi: 10.7150/thno.36037.", "ArticleIdList": ["10.7150/thno.36037", "PMC6691380", "31410189"]}, {"Citation": "Koundouros N., Poulogiannis G. Reprogramming of fatty acid metabolism in cancer. Br. J. Cancer. 2020;122:4\u201322. doi: 10.1038/s41416-019-0650-z.", "ArticleIdList": ["10.1038/s41416-019-0650-z", "PMC6964678", "31819192"]}, {"Citation": "DiNicolantonio J.J., O\u2019Keefe J.H. Effects of dietary fats on blood lipids: A review of direct comparison trials. Open Heart. 2018;5:871. doi: 10.1136/openhrt-2018-000871.", "ArticleIdList": ["10.1136/openhrt-2018-000871", "PMC6074619", "30094038"]}, {"Citation": "Wang Y., Viscarra J., Kim S.J., Sul H.S. Transcriptional regulation of hepatic lipogenesis. Nat. Rev. Mol. Cell Biol. 2015;16:678\u2013689. doi: 10.1038/nrm4074.", "ArticleIdList": ["10.1038/nrm4074", "PMC4884795", "26490400"]}, {"Citation": "Pollard T.D., Lippincott-Schwartz J., Earnshaw W.C., Johnson G.T., editors. Cell Biology. Elsevier; New Haven, Connecticut: 2017. Processing and Degradation of Cellular Components; pp. 393\u2013405."}, {"Citation": "Sharpe L.J., Brown A.J. Controlling cholesterol synthesis beyond 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR) J. Biol. Chem. 2013;288:18707\u201318715. doi: 10.1074/jbc.R113.479808.", "ArticleIdList": ["10.1074/jbc.R113.479808", "PMC3696645", "23696639"]}, {"Citation": "Adlakha Y.K., Khanna S., Singh R., Singh V.P., Agrawal A., Saini N. Pro-apoptotic miRNA-128-2 modulates ABCA1, ABCG1 and RXR\u03b1 expression and cholesterol homeostasis. Cell Death Dis. 2013;4:e780. doi: 10.1038/cddis.2013.301.", "ArticleIdList": ["10.1038/cddis.2013.301", "PMC3763462", "23990020"]}, {"Citation": "Ding X., Zhang W., Li S., Yang H. The role of cholesterol metabolism in cancer. Am. J. Cancer Res. 2019;9:219\u2013227.", "ArticleIdList": ["PMC6405981", "30906624"]}, {"Citation": "Sohn J., Lin H., Fritch M.R., Tuan R.S. Influence of cholesterol/caveolin-1/caveolae homeostasis on membrane properties and substrate adhesion characteristics of adult human mesenchymal stem cells. Stem Cell Res. Ther. 2018;9:86. doi: 10.1186/s13287-018-0830-4.", "ArticleIdList": ["10.1186/s13287-018-0830-4", "PMC5883280", "29615119"]}, {"Citation": "Sever R., Brugge J.S. Signal transduction in cancer. Cold Spring Harb. Perspect. Med. 2015;5:a006098. doi: 10.1101/cshperspect.a006098.", "ArticleIdList": ["10.1101/cshperspect.a006098", "PMC4382731", "25833940"]}, {"Citation": "Nwosu Z.C., Ebert M.P., Dooley S., Meyer C. Caveolin-1 in the regulation of cell metabolism: A cancer perspective. Mol. Cancer. 2016;15:71. doi: 10.1186/s12943-016-0558-7.", "ArticleIdList": ["10.1186/s12943-016-0558-7", "PMC5112640", "27852311"]}, {"Citation": "Liberti M.V., Locasale J.W. The Warburg Effect: How Does it Benefit Cancer Cells? Trends Biochem. Sci. 2016;41:211\u2013218. doi: 10.1016/j.tibs.2015.12.001.", "ArticleIdList": ["10.1016/j.tibs.2015.12.001", "PMC4783224", "26778478"]}, {"Citation": "Cheng C., Ru P., Geng F., Liu J., Yoo J.Y., Wu X., Cheng X., Euthine V., Hu P., Guo J.Y., et al. Glucose-Mediated N-glycosylation of SCAP Is Essential for SREBP-1 Activation and Tumor Growth. Cancer Cell. 2015;28:569\u2013581. doi: 10.1016/j.ccell.2015.09.021.", "ArticleIdList": ["10.1016/j.ccell.2015.09.021", "PMC4643405", "26555173"]}, {"Citation": "Kaszuba K., Grzybek M., Or\u0142owski A., Danne R., R\u00f3g T., Simons K., Coskun \u00dc., Vattulainen I. N-Glycosylation as determinant of epidermal growth factor receptor conformation in membranes. Proc. Natl. Acad. Sci. USA. 2015;112:4334\u20134339. doi: 10.1073/pnas.1503262112.", "ArticleIdList": ["10.1073/pnas.1503262112", "PMC4394299", "25805821"]}, {"Citation": "Rosenkranz A.A., Slastnikova T.A. Epidermal Growth Factor Receptor: Key to Selective Intracellular Delivery. Biochemistry. 2020;85:967\u2013993. doi: 10.1134/S0006297920090011.", "ArticleIdList": ["10.1134/S0006297920090011", "33050847"]}, {"Citation": "Metibemu D.S., Akinloye O.A., Akamo A.J., Ojo D.A., Okeowo O.T., Omotuyi I.O. Exploring receptor tyrosine kinases-inhibitors in Cancer treatments. Egypt. J. Med. Hum. Genet. 2019;20:35. doi: 10.1186/s43042-019-0035-0.", "ArticleIdList": ["10.1186/s43042-019-0035-0"]}, {"Citation": "Takahashi Y., Fukusato T. Animal Models of Liver Diseases. In: Conn P.M., editor. Animal Models for the Study of Human Disease. Elsevier Inc.; Lubbock, TX, USA: 2017. pp. 313\u2013339."}, {"Citation": "Golds E.E., Ciosek C.P., Hamilton J.A. Differential release of plasminogen activator and latent collagenase from mononuclear cell-stimulated synovial cells. Arthritis Rheum. 1983;26:15\u201321. doi: 10.1002/art.1780260103.", "ArticleIdList": ["10.1002/art.1780260103", "6297507"]}, {"Citation": "Kubala M.H., DeClerck Y.A. The plasminogen activator inhibitor-1 paradox in cancer: A mechanistic understanding. Cancer Metastasis Rev. 2019;38:483\u2013492. doi: 10.1007/s10555-019-09806-4.", "ArticleIdList": ["10.1007/s10555-019-09806-4", "PMC7001780", "31734763"]}, {"Citation": "Kubala M.H., Punj V., Placencio-Hickok V.R., Fang H., Fernandez G.E., Sposto R., DeClerck Y.A. Plasminogen Activator Inhibitor-1 Promotes the Recruitment and Polarization of Macrophages in Cancer. Cell Rep. 2018;25:2177\u20132191.e7. doi: 10.1016/j.celrep.2018.10.082.", "ArticleIdList": ["10.1016/j.celrep.2018.10.082", "PMC6876299", "30463014"]}, {"Citation": "Jacobo-Albavera L., Dom\u00ednguez-P\u00e9rez M., Medina-Leyte D.J., Gonz\u00e1lez-Garrido A., Villarreal-Molina T. The role of the atp-binding cassette a1 (Abca1) in human disease. Int. J. Mol. Sci. 2021;22:1593. doi: 10.3390/ijms22041593.", "ArticleIdList": ["10.3390/ijms22041593", "PMC7915494", "33562440"]}, {"Citation": "Bi D.P., Yin C.H., Zhang X.Y., Yang N.N., Xu J.Y. MIR-183 functions as an oncogene by targeting ABCA1 in colon cancer. Oncol. Rep. 2016;35:2873\u20132879. doi: 10.3892/or.2016.4631.", "ArticleIdList": ["10.3892/or.2016.4631", "26935154"]}, {"Citation": "Lee B.H., Taylor M.G., Robinet P., Smith J.D., Schweitzer J., Sehayek E., Falzarano S.M., Magi-Galluzzi C., Klein E.A., Ting A.H. Dysregulation of cholesterol homeostasis in human prostate cancer through loss of ABCA1. Cancer Res. 2013;73:1211\u20131218. doi: 10.1158/0008-5472.CAN-12-3128.", "ArticleIdList": ["10.1158/0008-5472.CAN-12-3128", "PMC3563867", "23233737"]}, {"Citation": "Shen W.J., Azhar S., Kraemer F.B. SR-B1: A Unique Multifunctional Receptor for Cholesterol Influx and Efflux. Annu. Rev. Physiol. 2018;80:95\u2013116. doi: 10.1146/annurev-physiol-021317-121550.", "ArticleIdList": ["10.1146/annurev-physiol-021317-121550", "PMC6376870", "29125794"]}, {"Citation": "Burgos R.A., Alarcon P., Quiroga J., Manosalva C., Hancke J. Andrographolide, an Anti-Inflammatory Multitarget Drug: All Roads Lead to Cellular Metabolism. Molecules. 2021;26:5. doi: 10.3390/molecules26010005.", "ArticleIdList": ["10.3390/molecules26010005", "PMC7792620", "33374961"]}, {"Citation": "Uribe-Querol E., Rosales C. Neutrophils in cancer: Two sides of the same coin. J. Immunol. Res. 2015;2015:983698. doi: 10.1155/2015/983698.", "ArticleIdList": ["10.1155/2015/983698", "PMC4706937", "26819959"]}, {"Citation": "Chang C.C., Duann Y.F., Yen T.L., Chen Y.Y., Jayakumar T., Ong E.T., Sheu J.R. Andrographolide, a novel NF-\u03baB inhibitor, inhibits vascular smooth muscle cell proliferation and cerebral endothelial cell inflammation. Acta Cardiol. Sin. 2014;30:308\u2013315.", "ArticleIdList": ["PMC4804993", "27122804"]}, {"Citation": "Farooqi A.A., Attar R., Uteuliyev Y.S., Alaaeddine N., de Sousa D.P., Xu B., Cho W.C. The Prowess of Andrographolide as a Natural Weapon in the War against Cancer. Cancers. 2020;12:2159. doi: 10.3390/cancers12082159.", "ArticleIdList": ["10.3390/cancers12082159", "PMC7465495", "32759728"]}, {"Citation": "Yuan M., Meng W., Liao W., Lian S. Andrographolide Antagonizes TNF-\u03b1-Induced IL-8 via Inhibition of NADPH Oxidase/ROS/NF-\u03baB and Src/MAPKs/AP-1 Axis in Human Colorectal Cancer HCT116 Cells. J. Agric. Food Chem. 2018;66:5139\u20135148. doi: 10.1021/acs.jafc.8b00810.", "ArticleIdList": ["10.1021/acs.jafc.8b00810", "29672044"]}, {"Citation": "Li Y., He S., Tang J., Ding N., Chu X., Cheng L., Ding X., Liang T., Feng S., Rahman S.U., et al. Andrographolide Inhibits Inflammatory Cytokines Secretion in LPS-Stimulated RAW264.7 Cells through Suppression of NF-\u03baB/MAPK Signaling Pathway. Evid.-Based Complement. Altern. Med. 2017;2017:8248142. doi: 10.1155/2017/8248142.", "ArticleIdList": ["10.1155/2017/8248142", "PMC5476883", "28676833"]}, {"Citation": "Ramos-Nino M.E. The Role of Chronic Inflammation in Obesity-Associated Cancers. ISRN Oncol. 2013;2013:697521. doi: 10.1155/2013/697521.", "ArticleIdList": ["10.1155/2013/697521", "PMC3683483", "23819063"]}, {"Citation": "Hu X., Li J., Fu M., Zhao X., Wang W. The JAK/STAT signaling pathway: From bench to clinic. Signal Transduct. Target. Ther. 2021;6:402. doi: 10.1038/s41392-021-00791-1.", "ArticleIdList": ["10.1038/s41392-021-00791-1", "PMC8617206", "34824210"]}, {"Citation": "Zhou J., Ong C.N., Hur G.M., Shen H.M. Inhibition of the JAK-STAT3 pathway by andrographolide enhances chemosensitivity of cancer cells to doxorubicin. Biochem. Pharmacol. 2009;79:1242\u20131250. doi: 10.1016/j.bcp.2009.12.014.", "ArticleIdList": ["10.1016/j.bcp.2009.12.014", "20026083"]}, {"Citation": "Xu D., Yin C., Wang S., Xiao Y. JAK-STAT in lipid metabolism of adipocytes. Jak-Stat. 2013;2:e27203. doi: 10.4161/jkst.27203.", "ArticleIdList": ["10.4161/jkst.27203", "PMC3906428", "24498541"]}, {"Citation": "Moresi V., Adamo S., Berghella L. The JAK/STAT pathway in skeletal muscle pathophysiology. Front. Physiol. 2019;10:500. doi: 10.3389/fphys.2019.00500.", "ArticleIdList": ["10.3389/fphys.2019.00500", "PMC6502894", "31114509"]}, {"Citation": "Liang F.P., Lin C.H., Kuo C.D., Chao H.P., Fu S.L. Suppression of v-Src transformation by andrographolide via degradation of the v-Src protein and attenuation of the Erk signaling pathway. J. Biol. Chem. 2008;283:5023\u20135033. doi: 10.1074/jbc.M705877200.", "ArticleIdList": ["10.1074/jbc.M705877200", "18086662"]}, {"Citation": "Mart\u00ednez-Lostao L., Anel A., Pardo J. How Do Cytotoxic Lymphocytes Kill Cancer Cells? Clin. Cancer Res. 2015;21:5047\u20135056. doi: 10.1158/1078-0432.CCR-15-0685.", "ArticleIdList": ["10.1158/1078-0432.CCR-15-0685", "26567364"]}, {"Citation": "Woo Y.M., Shin Y., Lee E.J., Lee S., Jeong S.H., Kong H.K., Park E.Y., Kim H.K., Han J., Chang M., et al. Inhibition of aerobic glycolysis represses Akt/mTOR/HIF-1\u03b1 axis and restores tamoxifen sensitivity in antiestrogen-resistant breast cancer cells. PLoS ONE. 2015;10:e0132285. doi: 10.1371/journal.pone.0132285.", "ArticleIdList": ["10.1371/journal.pone.0132285", "PMC4497721", "26158266"]}, {"Citation": "DeBerardinis R.J., Chandel N.S. Fundamentals of cancer metabolism. Sci. Adv. 2016;2:e1600200. doi: 10.1126/sciadv.1600200.", "ArticleIdList": ["10.1126/sciadv.1600200", "PMC4928883", "27386546"]}, {"Citation": "Ching C.B., Hansel D.E. Expanding therapeutic targets in bladder cancer: The PI3K/Akt/mTOR pathway. Nat. 2010;90:1406\u20131414. doi: 10.1038/labinvest.2010.133.", "ArticleIdList": ["10.1038/labinvest.2010.133", "20661228"]}, {"Citation": "Porta C., Paglino C., Mosca A. Targeting PI3K/Akt/mTOR signaling in cancer. Front. Oncol. 2014;4:64. doi: 10.3389/fonc.2014.00064.", "ArticleIdList": ["10.3389/fonc.2014.00064", "PMC3995050", "24782981"]}, {"Citation": "Karar J., Maity A. PI3K/AKT/mTOR Pathway in Angiogenesis. Front. Mol. Neurosci. 2011;4:51. doi: 10.3389/fnmol.2011.00051.", "ArticleIdList": ["10.3389/fnmol.2011.00051", "PMC3228996", "22144946"]}, {"Citation": "Lien E.C., Lyssiotis C.A., Cantley L.C. In: Metabolic Reprogramming by the PI3K-Akt-mTOR Pathway in Cancer BT\u2014Metabolism in Cancer. Cramer T., Schmitt C.A., editors. Springer International Publishing; Cham, Switzerland: 2016. pp. 39\u201372.", "ArticleIdList": ["27557534"]}, {"Citation": "Bossler F., Hoppe-Seyler K., Hoppe-Seyler F. PI3K/AKT/mTOR Signaling Regulates the Virus/Host Cell Crosstalk in HPV-Positive Cervical Cancer Cells. Int. J. Mol. Sci. 2019;20:2188. doi: 10.3390/ijms20092188.", "ArticleIdList": ["10.3390/ijms20092188", "PMC6539191", "31058807"]}, {"Citation": "Chun J.Y., Tummala R., Nadiminty N., Lou W., Liu C., Yang J., Evans C.P., Zhou Q., Gao A.C. Andrographolide, an herbal medicine, inhibits interleukin-6 expression and suppresses prostate cancer cell growth. Genes Cancer. 2010;1:868\u2013876. doi: 10.1177/1947601910383416.", "ArticleIdList": ["10.1177/1947601910383416", "PMC3063649", "21442031"]}, {"Citation": "Bose S., Banerjee S., Mondal A., Chakraborty U., Pumarol J., Croley C.R., Bishayee A. Targeting the JAK/STAT Signaling Pathway Using Phytocompounds for Cancer Prevention and Therapy. Cells. 2020;9:1451. doi: 10.3390/cells9061451.", "ArticleIdList": ["10.3390/cells9061451", "PMC7348822", "32545187"]}, {"Citation": "Islam M.T., Ali E.S., Uddin S.J., Islam M.A., Shaw S., Khan I.N., Saravi S.S.S., Ahmad S., Rehman S., Gupta V.K., et al. Andrographolide, a diterpene lactone from Andrographis paniculata and its therapeutic promises in cancer. Cancer Lett. 2018;420:129\u2013145. doi: 10.1016/j.canlet.2018.01.074.", "ArticleIdList": ["10.1016/j.canlet.2018.01.074", "29408515"]}, {"Citation": "Li X., Tian R., Liu L., Wang L., He D., Cao K., Ma J.K., Huang C. Andrographolide enhanced radiosensitivity by downregulating glycolysis via the inhibition of the PI3K-Akt-mTOR signaling pathway in HCT116 colorectal cancer cells. J. Int. Med. Res. 2020;48:300060520946169. doi: 10.1177/0300060520946169.", "ArticleIdList": ["10.1177/0300060520946169", "PMC7427152", "32787737"]}, {"Citation": "Alugoju P., Chaitanya N.S.N., Krishna Swamy V.K.D., Kancharla P.K. Phytotherapy for breast cancer. In: Malla R.R., Nagaraju G.P., editors. A Theranostic and Precision Medicine Approach for Female-Specific Cancers. Academic Press; Andhra Pradesh, India: 2021. pp. 129\u2013163."}, {"Citation": "Lapeyre-Prost A., Terme M., Pernot S., Pointet A.L., Voron T., Tartour E., Taieb J. Immunomodulatory Activity of VEGF in Cancer. Int. Rev. Cell Mol. Biol. 2016;330:295\u2013342. doi: 10.1016/BS.IRCMB.2016.09.007.", "ArticleIdList": ["10.1016/BS.IRCMB.2016.09.007", "28215534"]}, {"Citation": "Paul T., Basu S., Saha N.C. Anticancer effect of Andrographis paniculata by suppression of tumor altered hypoxia signaling cascade in mouse melanoma cells. J. Cancer Res. Pract. 2022;6:123. doi: 10.4103/JCRP.JCRP_9_19.", "ArticleIdList": ["10.4103/JCRP.JCRP_9_19"]}, {"Citation": "Lu C.Y., Yang Y.C., Li C.C., Liu K.L., Lii C.K., Chen H.W. Andrographolide inhibits TNF\u03b1-induced ICAM-1 expression via suppression of NADPH oxidase activation and induction of HO-1 and GCLM expression through the PI3K/Akt/Nrf2 and PI3K/Akt/AP-1 pathways in human endothelial cells. Biochem. Pharmacol. 2014;9:40\u201350. doi: 10.1016/j.bcp.2014.06.024.", "ArticleIdList": ["10.1016/j.bcp.2014.06.024", "24998495"]}, {"Citation": "Benedicto A., Romayor I., Arteta B. Role of liver ICAM-1 in metastasis. Oncol. Lett. 2017;14:3883\u20133892. doi: 10.3892/ol.2017.6700.", "ArticleIdList": ["10.3892/ol.2017.6700", "PMC5604125", "28943897"]}, {"Citation": "Lim S.C., Jeon H.J., Kee K.H., Lee M.J., Hong R., Han S.I. Andrographolide induces apoptotic and non-apoptotic death and enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in gastric cancer cells. Oncol. Lett. 2017;13:3837\u20133844. doi: 10.3892/ol.2017.5923.", "ArticleIdList": ["10.3892/ol.2017.5923", "PMC5431559", "28529596"]}, {"Citation": "Campbell K.J., Tait S.W.G. Targeting BCL-2 regulated apoptosis in cancer. Open Biol. 2018;8:180002. doi: 10.1098/rsob.180002.", "ArticleIdList": ["10.1098/rsob.180002", "PMC5990650", "29769323"]}, {"Citation": "Islam M.T. Andrographolide, a new hope in the prevention and treatment of metabolic syndrome. Front. Pharmacol. 2017;8:571. doi: 10.3389/fphar.2017.00571.", "ArticleIdList": ["10.3389/fphar.2017.00571", "PMC5572404", "28878680"]}, {"Citation": "Dhanasekaran D.N., Reddy E.P. JNK signaling in apoptosis. Oncogene. 2008;27:6245\u20136251. doi: 10.1038/onc.2008.301.", "ArticleIdList": ["10.1038/onc.2008.301", "PMC3063296", "18931691"]}, {"Citation": "Chen Y.Y., Hsu M.J., Hsieh C.Y., Lee L.W., Chen Z.C., Sheu J.R. Andrographolide inhibits nuclear factor-B activation through JNK-Akt-p65 signaling cascade in tumor necrosis factor-\u03b1-Stimulated vascular smooth muscle cells. Sci. World J. 2014;2014:130381. doi: 10.1155/2014/130381.", "ArticleIdList": ["10.1155/2014/130381", "PMC4121194", "25114952"]}, {"Citation": "Micheau O. Cellular FLICE-inhibitory protein: An attractive therapeutic target? Expert Opin. Ther. Targets. 2003;7:559\u2013573. doi: 10.1517/14728222.7.4.559.", "ArticleIdList": ["10.1517/14728222.7.4.559", "PMC2984612", "12885274"]}, {"Citation": "Gardner J., Ghorpade A. Tissue Inhibitor of Metalloproteinase (TIMP)-1: The TIMPed Balance of Matrix Metalloproteinases in the Central Nervous System. J. Neurosci. Res. 2003;74:801\u2013806. doi: 10.1002/jnr.10835.", "ArticleIdList": ["10.1002/jnr.10835", "PMC3857704", "14648584"]}, {"Citation": "Li L., Yue G.G.L., Lee J.K.M., Wong E.C.W., Fung K.P., Yu J., Lau C.B.S., Chiu P.W.Y. The adjuvant value of Andrographis paniculata in metastatic esophageal cancer treatment\u2014From preclinical perspectives. Sci. Rep. 2017;7:854. doi: 10.1038/s41598-017-00934-x.", "ArticleIdList": ["10.1038/s41598-017-00934-x", "PMC5429803", "28405006"]}, {"Citation": "Chao W.W., Kuo Y.H., Hsieh S.L., Lin B.F. Inhibitory effects of ethyl acetate extract of Andrographis paniculata on NF-\u03baB trans-activation activity and LPS-induced acute inflammation in mice. Evid.-Based Complement. Altern. Med. 2011;2011:254531. doi: 10.1093/ecam/nep120.", "ArticleIdList": ["10.1093/ecam/nep120", "PMC3096457", "19745004"]}, {"Citation": "Rajagopal S., Kumar R.A., Deevi D.S., Satyanarayana C., Rajagopalan R. Andrographolide, a potential cancer therapeutic agent isolated from Andrographis paniculata. J. Exp. Ther. Oncol. 2003;3:147\u2013158. doi: 10.1046/j.1359-4117.2003.01090.x.", "ArticleIdList": ["10.1046/j.1359-4117.2003.01090.x", "14641821"]}, {"Citation": "Jayakumar T., Hsieh C.Y., Lee J.J., Sheu J.R. Experimental and clinical pharmacology of Andrographis paniculata and its major bioactive phytoconstituent andrographolide. Evid.-Based Complement. Altern. Med. 2013;2013:846740. doi: 10.1155/2013/846740.", "ArticleIdList": ["10.1155/2013/846740", "PMC3619690", "23634174"]}, {"Citation": "Shen Y.C., Chen C.F., Chiou W.F. Andrographolide prevents oxygen radical production by human neutrophils: Possible mechanism(s) involved in its anti-inflammatory effect. Br. J. Pharmacol. 2002;135:399\u2013406. doi: 10.1038/sj.bjp.0704493.", "ArticleIdList": ["10.1038/sj.bjp.0704493", "PMC1573154", "11815375"]}, {"Citation": "Arcaro A., Guerreiro A. The Phosphoinositide 3-Kinase Pathway in Human Cancer: Genetic Alterations and Therapeutic Implications. Curr. Genom. 2007;8:271\u2013306. doi: 10.2174/138920207782446160.", "ArticleIdList": ["10.2174/138920207782446160", "PMC2652403", "19384426"]}, {"Citation": "Barthel S.R., Gavino J.D., Descheny L., Dimitroff C.J. Targeting selectins and selectin ligands in inflammation and cancer. Expert Opin. Ther. Targets. 2007;11:1473\u20131491. doi: 10.1517/14728222.11.11.1473.", "ArticleIdList": ["10.1517/14728222.11.11.1473", "PMC2559865", "18028011"]}, {"Citation": "Oh B.Y., Hong H.K., Lee W.Y., Cho Y.B. Animal models of colorectal cancer with liver metastasis. Cancer Lett. 2016;387:114\u2013120. doi: 10.1016/j.canlet.2016.01.048.", "ArticleIdList": ["10.1016/j.canlet.2016.01.048", "26850374"]}, {"Citation": "Wang H., Yu Z., Huo S., Chen Z., Ou Z., Mai J., Ding S., Zhang J. Overexpression of ELF3 facilitates cell growth and metastasis through PI3K/Akt and ERK signaling pathways in non-small cell lung cancer. Int. J. Biochem. Cell Biol. 2017;94:98\u2013106. doi: 10.1016/j.biocel.2017.12.002.", "ArticleIdList": ["10.1016/j.biocel.2017.12.002", "29208568"]}, {"Citation": "Peng Y., Wang Y., Zhou C., Mei W., Zeng C. PI3K/Akt/mTOR Pathway and Its Role in Cancer Therapeutics: Are We Making Headway? Front. Oncol. 2022;12:1201. doi: 10.3389/fonc.2022.819128.", "ArticleIdList": ["10.3389/fonc.2022.819128", "PMC8987494", "35402264"]}, {"Citation": "Tehranian C., Fankhauser L., Harter P.N. The PI3K / Akt / mTOR pathway as a preventive target in melanoma brain metastasis. Neuro-oncolgy. 2022;24:213\u2013225. doi: 10.1093/neuonc/noab159.", "ArticleIdList": ["10.1093/neuonc/noab159", "PMC8804893", "34216217"]}, {"Citation": "Sadeghi N., Gerber D.E. Targeting the PI3K pathway for cancer therapy. Future Med. Chem. 2012;4:1153\u20131169. doi: 10.4155/fmc.12.56.", "ArticleIdList": ["10.4155/fmc.12.56", "PMC4276042", "22709255"]}, {"Citation": "Arafeh R., Samuels Y. PIK3CA in cancer: The past 30 years. Semin. Cancer Biol. 2019;59:36\u201349. doi: 10.1016/j.semcancer.2019.02.002.", "ArticleIdList": ["10.1016/j.semcancer.2019.02.002", "30742905"]}, {"Citation": "Ippen F.M., Grosch J.K., Subramanian M., Kuter B.M.F., Liederer B.M., Plise E.G., Mora J.L., Nayyar N., Schmidt S.P., Giobbie-Hurder A., et al. Targeting the PI3K/Akt/mTOR pathway with the pan-Akt inhibitor GDC-0068 in PIK3CA-mutant breast cancer brain metastases. Neuro. Oncol. 2019;21:1401\u20131411. doi: 10.1093/neuonc/noz105.", "ArticleIdList": ["10.1093/neuonc/noz105", "PMC6827829", "31173106"]}, {"Citation": "Yang H., Guan L., Li S., Jiang Y., Xiong N., Li L., Wu C., Zeng H., Liu Y. Mechanosensitive caveolin-1 activation-induced PI3K/Akt/mTOR signaling pathway promotes breast cancer motility, invadopodia formation and metastasis in vivo. Oncotarget. 2016;7:16227\u201316247. doi: 10.18632/oncotarget.7583.", "ArticleIdList": ["10.18632/oncotarget.7583", "PMC4941310", "26919102"]}, {"Citation": "Kiyosawa N., Watanabe K., Toyama K., Ishizuka H. Circulating miRNA Signature as a Potential Biomarker for the Prediction of Analgesic Efficacy of Hydromorphone. Int. J. Mol. Sci. 2019;20:1665. doi: 10.3390/ijms20071665.", "ArticleIdList": ["10.3390/ijms20071665", "PMC6480077", "30987164"]}, {"Citation": "Xue T.M., Tao L.D., Zhang M., Xu G.C., Zhang J., Zhang P.J. miR-20b overexpression is predictive of poor prognosis in gastric cancer. Onco. Targets. Ther. 2015;8:1871\u20131876. doi: 10.2147/OTT.S85236.", "ArticleIdList": ["10.2147/OTT.S85236", "PMC4521667", "26244024"]}, {"Citation": "Streleckiene G., Inciuraite R., Juzenas S., Salteniene V., Steponaitiene R., Gyvyte U., Kiudelis G., Leja M., Ruzgys P., Satkauskas S., et al. miR-20b and miR-451a Are Involved in Gastric Carcinogenesis through the PI3K/AKT/mTOR Signaling Pathway: Data from Gastric Cancer Patients, Cell Lines and Ins-Gas Mouse Model. Int. J. Mol. Sci. 2020;21:877. doi: 10.3390/ijms21030877.", "ArticleIdList": ["10.3390/ijms21030877", "PMC7038213", "32013265"]}, {"Citation": "Rani A., Murphy J.J. STAT5 in Cancer and Immunity. J. Interferon Cytokine Res. 2015;36:226\u2013237. doi: 10.1089/jir.2015.0054.", "ArticleIdList": ["10.1089/jir.2015.0054", "26716518"]}, {"Citation": "Groner B., Manstein V. von Jak Stat signaling and cancer: Opportunities, benefits and side effects of targeted inhibition. Mol. Cell. Endocrinol. 2017;451:1\u201314. doi: 10.1016/j.mce.2017.05.033.", "ArticleIdList": ["10.1016/j.mce.2017.05.033", "28576744"]}, {"Citation": "Lin W.H., Chang Y.W., Hong M.X., Hsu T.C., Lee K.C., Lin C., Lee J.L. STAT3 phosphorylation at Ser727 and Tyr705 differentially regulates the EMT\u2013MET switch and cancer metastasis. Oncogene. 2020;40:791\u2013805. doi: 10.1038/s41388-020-01566-8.", "ArticleIdList": ["10.1038/s41388-020-01566-8", "PMC7843420", "33262462"]}, {"Citation": "Udhane V., Maranto C., Hoang D.T., Gu L., Erickson A., Devi S., Talati P.G., Banerjee A., Iczkowski K.A., Jacobsohn K., et al. Enzalutamide-Induced Feed-Forward Signaling Loop Promotes Therapy-Resistant Prostate Cancer Growth Providing an Exploitable Molecular Target for Jak2 Inhibitors. Mol. Cancer Ther. 2020;19:231\u2013246. doi: 10.1158/1535-7163.MCT-19-0508.", "ArticleIdList": ["10.1158/1535-7163.MCT-19-0508", "PMC6946850", "31548294"]}, {"Citation": "Cui Y., Yang J., Bai Y., Li Q.W., Yao Y., Liu C., Wu F., Zhang J., Zhang Y. ENC1 Facilitates Colorectal Carcinoma Tumorigenesis and Metastasis via JAK2/STAT5/AKT Axis-Mediated Epithelial Mesenchymal Transition and Stemness. Front. Cell Dev. Biol. 2021;9:616887. doi: 10.3389/fcell.2021.616887.", "ArticleIdList": ["10.3389/fcell.2021.616887", "PMC8010667", "33816464"]}, {"Citation": "Cui C., Cheng X., Yan L., Ding H., Guan X., Zhang W., Tian X., Hao C. Downregulation of TfR1 promotes progression of colorectal cancer via the JAK/STAT pathway. Cancer Manag. Res. 2019;11:6323\u20136341. doi: 10.2147/CMAR.S198911.", "ArticleIdList": ["10.2147/CMAR.S198911", "PMC6628123", "31372038"]}, {"Citation": "Bottos A., Gotthardt D., Gill J.W., Gattelli A., Frei A., Tzankov A., Sexl V., Wodnar-Filipowicz A., Hynes N.E. Decreased NK-cell tumour immunosurveillance consequent to JAK inhibition enhances metastasis in breast cancer models. Nat. Commun. 2016;7:12258. doi: 10.1038/ncomms12258.", "ArticleIdList": ["10.1038/ncomms12258", "PMC4947169", "27406745"]}, {"Citation": "Campbell H., Fleming N., Roth I., Mehta S., Wiles A., Williams G., Vennin C., Arsic N., Parkin A., Pajic M., et al. \u0394133p53 isoform promotes tumour invasion and metastasis via interleukin-6 activation of JAK-STAT and RhoA-ROCK signaling. Nat. Commun. 2018;9:254. doi: 10.1038/s41467-017-02408-0.", "ArticleIdList": ["10.1038/s41467-017-02408-0", "PMC5772473", "29343721"]}, {"Citation": "Binnemars-Postma K., Bansal R., Storm G., Prakash J. Targeting the Stat6 pathway in tumor-associated macrophages reduces tumor growth and metastatic niche formation in breast cancer. FASEB J. 2017;32:969\u2013978. doi: 10.1096/fj.201700629R.", "ArticleIdList": ["10.1096/fj.201700629R", "29066614"]}, {"Citation": "Lee C.C., Lin J.C., Hwang W.L., Kuo Y.J., Chen H.K., Tai S.K., Lin C.C., Yang M.H. Macrophage-secreted interleukin-35 regulates cancer cell plasticity to facilitate metastatic colonization. Nat. Commun. 2018;9:3763. doi: 10.1038/s41467-018-06268-0.", "ArticleIdList": ["10.1038/s41467-018-06268-0", "PMC6138674", "30218063"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "4", "Day": "8"}, {"Year": "2022", "Month": "5", "Day": "21"}, {"Year": "2022", "Month": "5", "Day": "23"}, {"Year": "2022", "Month": "6", "Day": "10", "Hour": "1", "Minute": "14"}, {"Year": "2022", "Month": "6", "Day": "11", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "6", "Day": "14", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "5", "Day": "26"}], "PublicationStatus": "epublish", "ArticleIdList": ["35682652", "PMC9181071", "10.3390/ijms23115972", "ijms23115972"]}}], "PubmedBookArticle": []}